Author Correction: A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies

Παρόμοια τεκμήρια

• A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies
  ανά: Hsia, Chih-Hsuan, κ.ά.
  Έκδοση: (2017)
• Synthetic Ruthenium Complex TQ-6 Potently Recovers Cerebral Ischemic Stroke: Attenuation of Microglia and Platelet Activation
  ανά: Hsia, Chih-Hsuan, κ.ά.
  Έκδοση: (2020)
• Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling
  ανά: Khamrang, Themmila, κ.ά.
  Έκδοση: (2017)
• Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy
  ανά: Jayakumar, Thanasekaran, κ.ά.
  Έκδοση: (2018)
• Mechanisms of TQ-6, a Novel Ruthenium-Derivative Compound, against Lipopolysaccharide-Induced In Vitro Macrophage Activation and Liver Injury in Experimental Mice: The Crucial Role of p38 MAPK and NF-κB Signaling
  ανά: Hsia, Chih-Hsuan, κ.ά.
  Έκδοση: (2018)